Gene expression analysis Comprehensive Study by Type (Consumables (Reagents, DNA Chips), Instruments (PCR, NGS, Microarray)), Application (Diagnostics, Pharmacogenomics, Toxicology, Compare Expression Levels of One or More Genes from Biomarkers), Techniques Types (Absolute Quantitation Techniques (Serial Analysis of Gene Expression), Microarrays), Service Types (Gene Expression Profiling Services, Bioinformatics Solutions) Players and Region - Global Market Outlook to 2030

Gene expression analysis Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 10.13%  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Gene expression analysis
Gene expression analysis studies the activity of the formation of a gene product from its coding gene. It is an indicator of biological activity of changing gene expression pattern, this is a widely used the approach in research, clinical and pharmaceutical to understand individual gene. It is the study of gene products by imaging, amplification, probe hybridization or sequencing-based detection methods. Gene expression is the method to extract information from a genetic material that can be exploited for the assembly of a functional gene product. With the help of gene expression, the genetic code on a DNA can be studied.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR10.13%


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Gene expression analysis market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Illumina Inc. (United States), Thermo Fisher Scientific (United States), Bio-Rad Laboratories (United States), F. Hoffmann-La Roche Ltd. (Switzerland), Ge Healthcare (United States), Pacific Biosciences of California (Unites States), Bgi (Denmark), Perkinelmer (United States), Agilent Technologies Inc. (United States) and Qiagen N.V (Germany) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Gene expression analysis market by Type (Consumables (Reagents, DNA Chips) and Instruments (PCR, NGS, Microarray)), Application (Diagnostics, Pharmacogenomics, Toxicology and Compare Expression Levels of One or More Genes from Biomarkers) and Region.



On the basis of geography, the market of Gene expression analysis has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Techniques Types, the sub-segment i.e. Absolute Quantitation Techniques (Serial Analysis of Gene Expression) will boost the Gene expression analysis market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Service Types, the sub-segment i.e. Gene Expression Profiling Services will boost the Gene expression analysis market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Real-Time PCR Has Risen As the Most Popularly Used Approach in Studies

Market Growth Drivers:
Decreasing Cost of Sequencing, High Availability of Gene Expression Databases and Growing Application Areas of Genomics

Challenges:
Lack of Skilled Labor Is Become Hurdle For Innovations in Firm

Restraints:
High Cost of Instrument Will Lead To Decline the Market

Opportunities:
Strong Requirement in High Volume of Research Studies Involving Gene Expression Analysis

Market Leaders and their expansionary development strategies
In February 17, 2024, XOMA Corp. acquires Kinnate Biopharma, a US-based cancer drug developer, for an undisclosed amount. This deal doesn't directly focus on gene expression analysis but could potentially involve related technologies used in drug development.
In January 10, 2024, NanoString Technologies launches the GeoMx DSP spatial molecular imager. This new product allows researchers to visualize gene expression at the single-cell level within tissues, providing a deeper understanding of complex biological processes.


Key Target Audience
Pharma and Biotech Companies and Research Centers

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Consumables (Reagents, DNA Chips)
  • Instruments (PCR, NGS, Microarray)
By Application
  • Diagnostics
  • Pharmacogenomics
  • Toxicology
  • Compare Expression Levels of One or More Genes from Biomarkers
By Techniques Types
  • Absolute Quantitation Techniques (Serial Analysis of Gene Expression)
  • Microarrays

By Service Types
  • Gene Expression Profiling Services
  • Bioinformatics Solutions

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Decreasing Cost of Sequencing
      • 3.2.2. High Availability of Gene Expression Databases
      • 3.2.3. Growing Application Areas of Genomics
    • 3.3. Market Challenges
      • 3.3.1. Lack of Skilled Labor Is Become Hurdle For Innovations in Firm
    • 3.4. Market Trends
      • 3.4.1. Real-Time PCR Has Risen As the Most Popularly Used Approach in Studies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Gene expression analysis, by Type, Application, Techniques Types, Service Types and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Gene expression analysis (Value)
      • 5.2.1. Global Gene expression analysis by: Type (Value)
        • 5.2.1.1. Consumables (Reagents, DNA Chips)
        • 5.2.1.2. Instruments (PCR, NGS, Microarray)
      • 5.2.2. Global Gene expression analysis by: Application (Value)
        • 5.2.2.1. Diagnostics
        • 5.2.2.2. Pharmacogenomics
        • 5.2.2.3. Toxicology
        • 5.2.2.4. Compare Expression Levels of One or More Genes from Biomarkers
      • 5.2.3. Global Gene expression analysis by: Techniques Types (Value)
        • 5.2.3.1. Absolute Quantitation Techniques (Serial Analysis of Gene Expression)
        • 5.2.3.2. Microarrays
      • 5.2.4. Global Gene expression analysis by: Service Types (Value)
        • 5.2.4.1. Gene Expression Profiling Services
        • 5.2.4.2. Bioinformatics Solutions
      • 5.2.5. Global Gene expression analysis Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Gene expression analysis (Price)
      • 5.3.1. Global Gene expression analysis by: Type (Price)
  • 6. Gene expression analysis: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Illumina Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Thermo Fisher Scientific (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Bio-Rad Laboratories (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. F. Hoffmann-La Roche Ltd. (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Ge Healthcare (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Pacific Biosciences of California (Unites States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Bgi (Denmark)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Perkinelmer (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Agilent Technologies Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Qiagen N.V (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Appendix
    • 7.1. Acronyms
  • 8. Methodology and Data Source
    • 8.1. Methodology/Research Approach
      • 8.1.1. Research Programs/Design
      • 8.1.2. Market Size Estimation
      • 8.1.3. Market Breakdown and Data Triangulation
    • 8.2. Data Source
      • 8.2.1. Secondary Sources
      • 8.2.2. Primary Sources
    • 8.3. Disclaimer
List of Tables
  • Table 1. Gene expression analysis: by Type(USD Million)
  • Table 2. Gene expression analysis Consumables (Reagents, DNA Chips) , by Region USD Million (2018-2023)
  • Table 3. Gene expression analysis Instruments (PCR, NGS, Microarray) , by Region USD Million (2018-2023)
  • Table 4. Gene expression analysis: by Application(USD Million)
  • Table 5. Gene expression analysis Diagnostics , by Region USD Million (2018-2023)
  • Table 6. Gene expression analysis Pharmacogenomics , by Region USD Million (2018-2023)
  • Table 7. Gene expression analysis Toxicology , by Region USD Million (2018-2023)
  • Table 8. Gene expression analysis Compare Expression Levels of One or More Genes from Biomarkers , by Region USD Million (2018-2023)
  • Table 9. Gene expression analysis: by Techniques Types(USD Million)
  • Table 10. Gene expression analysis Absolute Quantitation Techniques (Serial Analysis of Gene Expression) , by Region USD Million (2018-2023)
  • Table 11. Gene expression analysis Microarrays , by Region USD Million (2018-2023)
  • Table 12. Gene expression analysis: by Service Types(USD Million)
  • Table 13. Gene expression analysis Gene Expression Profiling Services , by Region USD Million (2018-2023)
  • Table 14. Gene expression analysis Bioinformatics Solutions , by Region USD Million (2018-2023)
  • Table 15. South America Gene expression analysis, by Country USD Million (2018-2023)
  • Table 16. South America Gene expression analysis, by Type USD Million (2018-2023)
  • Table 17. South America Gene expression analysis, by Application USD Million (2018-2023)
  • Table 18. South America Gene expression analysis, by Techniques Types USD Million (2018-2023)
  • Table 19. South America Gene expression analysis, by Service Types USD Million (2018-2023)
  • Table 20. Brazil Gene expression analysis, by Type USD Million (2018-2023)
  • Table 21. Brazil Gene expression analysis, by Application USD Million (2018-2023)
  • Table 22. Brazil Gene expression analysis, by Techniques Types USD Million (2018-2023)
  • Table 23. Brazil Gene expression analysis, by Service Types USD Million (2018-2023)
  • Table 24. Argentina Gene expression analysis, by Type USD Million (2018-2023)
  • Table 25. Argentina Gene expression analysis, by Application USD Million (2018-2023)
  • Table 26. Argentina Gene expression analysis, by Techniques Types USD Million (2018-2023)
  • Table 27. Argentina Gene expression analysis, by Service Types USD Million (2018-2023)
  • Table 28. Rest of South America Gene expression analysis, by Type USD Million (2018-2023)
  • Table 29. Rest of South America Gene expression analysis, by Application USD Million (2018-2023)
  • Table 30. Rest of South America Gene expression analysis, by Techniques Types USD Million (2018-2023)
  • Table 31. Rest of South America Gene expression analysis, by Service Types USD Million (2018-2023)
  • Table 32. Asia Pacific Gene expression analysis, by Country USD Million (2018-2023)
  • Table 33. Asia Pacific Gene expression analysis, by Type USD Million (2018-2023)
  • Table 34. Asia Pacific Gene expression analysis, by Application USD Million (2018-2023)
  • Table 35. Asia Pacific Gene expression analysis, by Techniques Types USD Million (2018-2023)
  • Table 36. Asia Pacific Gene expression analysis, by Service Types USD Million (2018-2023)
  • Table 37. China Gene expression analysis, by Type USD Million (2018-2023)
  • Table 38. China Gene expression analysis, by Application USD Million (2018-2023)
  • Table 39. China Gene expression analysis, by Techniques Types USD Million (2018-2023)
  • Table 40. China Gene expression analysis, by Service Types USD Million (2018-2023)
  • Table 41. Japan Gene expression analysis, by Type USD Million (2018-2023)
  • Table 42. Japan Gene expression analysis, by Application USD Million (2018-2023)
  • Table 43. Japan Gene expression analysis, by Techniques Types USD Million (2018-2023)
  • Table 44. Japan Gene expression analysis, by Service Types USD Million (2018-2023)
  • Table 45. India Gene expression analysis, by Type USD Million (2018-2023)
  • Table 46. India Gene expression analysis, by Application USD Million (2018-2023)
  • Table 47. India Gene expression analysis, by Techniques Types USD Million (2018-2023)
  • Table 48. India Gene expression analysis, by Service Types USD Million (2018-2023)
  • Table 49. South Korea Gene expression analysis, by Type USD Million (2018-2023)
  • Table 50. South Korea Gene expression analysis, by Application USD Million (2018-2023)
  • Table 51. South Korea Gene expression analysis, by Techniques Types USD Million (2018-2023)
  • Table 52. South Korea Gene expression analysis, by Service Types USD Million (2018-2023)
  • Table 53. Taiwan Gene expression analysis, by Type USD Million (2018-2023)
  • Table 54. Taiwan Gene expression analysis, by Application USD Million (2018-2023)
  • Table 55. Taiwan Gene expression analysis, by Techniques Types USD Million (2018-2023)
  • Table 56. Taiwan Gene expression analysis, by Service Types USD Million (2018-2023)
  • Table 57. Australia Gene expression analysis, by Type USD Million (2018-2023)
  • Table 58. Australia Gene expression analysis, by Application USD Million (2018-2023)
  • Table 59. Australia Gene expression analysis, by Techniques Types USD Million (2018-2023)
  • Table 60. Australia Gene expression analysis, by Service Types USD Million (2018-2023)
  • Table 61. Rest of Asia-Pacific Gene expression analysis, by Type USD Million (2018-2023)
  • Table 62. Rest of Asia-Pacific Gene expression analysis, by Application USD Million (2018-2023)
  • Table 63. Rest of Asia-Pacific Gene expression analysis, by Techniques Types USD Million (2018-2023)
  • Table 64. Rest of Asia-Pacific Gene expression analysis, by Service Types USD Million (2018-2023)
  • Table 65. Europe Gene expression analysis, by Country USD Million (2018-2023)
  • Table 66. Europe Gene expression analysis, by Type USD Million (2018-2023)
  • Table 67. Europe Gene expression analysis, by Application USD Million (2018-2023)
  • Table 68. Europe Gene expression analysis, by Techniques Types USD Million (2018-2023)
  • Table 69. Europe Gene expression analysis, by Service Types USD Million (2018-2023)
  • Table 70. Germany Gene expression analysis, by Type USD Million (2018-2023)
  • Table 71. Germany Gene expression analysis, by Application USD Million (2018-2023)
  • Table 72. Germany Gene expression analysis, by Techniques Types USD Million (2018-2023)
  • Table 73. Germany Gene expression analysis, by Service Types USD Million (2018-2023)
  • Table 74. France Gene expression analysis, by Type USD Million (2018-2023)
  • Table 75. France Gene expression analysis, by Application USD Million (2018-2023)
  • Table 76. France Gene expression analysis, by Techniques Types USD Million (2018-2023)
  • Table 77. France Gene expression analysis, by Service Types USD Million (2018-2023)
  • Table 78. Italy Gene expression analysis, by Type USD Million (2018-2023)
  • Table 79. Italy Gene expression analysis, by Application USD Million (2018-2023)
  • Table 80. Italy Gene expression analysis, by Techniques Types USD Million (2018-2023)
  • Table 81. Italy Gene expression analysis, by Service Types USD Million (2018-2023)
  • Table 82. United Kingdom Gene expression analysis, by Type USD Million (2018-2023)
  • Table 83. United Kingdom Gene expression analysis, by Application USD Million (2018-2023)
  • Table 84. United Kingdom Gene expression analysis, by Techniques Types USD Million (2018-2023)
  • Table 85. United Kingdom Gene expression analysis, by Service Types USD Million (2018-2023)
  • Table 86. Netherlands Gene expression analysis, by Type USD Million (2018-2023)
  • Table 87. Netherlands Gene expression analysis, by Application USD Million (2018-2023)
  • Table 88. Netherlands Gene expression analysis, by Techniques Types USD Million (2018-2023)
  • Table 89. Netherlands Gene expression analysis, by Service Types USD Million (2018-2023)
  • Table 90. Rest of Europe Gene expression analysis, by Type USD Million (2018-2023)
  • Table 91. Rest of Europe Gene expression analysis, by Application USD Million (2018-2023)
  • Table 92. Rest of Europe Gene expression analysis, by Techniques Types USD Million (2018-2023)
  • Table 93. Rest of Europe Gene expression analysis, by Service Types USD Million (2018-2023)
  • Table 94. MEA Gene expression analysis, by Country USD Million (2018-2023)
  • Table 95. MEA Gene expression analysis, by Type USD Million (2018-2023)
  • Table 96. MEA Gene expression analysis, by Application USD Million (2018-2023)
  • Table 97. MEA Gene expression analysis, by Techniques Types USD Million (2018-2023)
  • Table 98. MEA Gene expression analysis, by Service Types USD Million (2018-2023)
  • Table 99. Middle East Gene expression analysis, by Type USD Million (2018-2023)
  • Table 100. Middle East Gene expression analysis, by Application USD Million (2018-2023)
  • Table 101. Middle East Gene expression analysis, by Techniques Types USD Million (2018-2023)
  • Table 102. Middle East Gene expression analysis, by Service Types USD Million (2018-2023)
  • Table 103. Africa Gene expression analysis, by Type USD Million (2018-2023)
  • Table 104. Africa Gene expression analysis, by Application USD Million (2018-2023)
  • Table 105. Africa Gene expression analysis, by Techniques Types USD Million (2018-2023)
  • Table 106. Africa Gene expression analysis, by Service Types USD Million (2018-2023)
  • Table 107. North America Gene expression analysis, by Country USD Million (2018-2023)
  • Table 108. North America Gene expression analysis, by Type USD Million (2018-2023)
  • Table 109. North America Gene expression analysis, by Application USD Million (2018-2023)
  • Table 110. North America Gene expression analysis, by Techniques Types USD Million (2018-2023)
  • Table 111. North America Gene expression analysis, by Service Types USD Million (2018-2023)
  • Table 112. United States Gene expression analysis, by Type USD Million (2018-2023)
  • Table 113. United States Gene expression analysis, by Application USD Million (2018-2023)
  • Table 114. United States Gene expression analysis, by Techniques Types USD Million (2018-2023)
  • Table 115. United States Gene expression analysis, by Service Types USD Million (2018-2023)
  • Table 116. Canada Gene expression analysis, by Type USD Million (2018-2023)
  • Table 117. Canada Gene expression analysis, by Application USD Million (2018-2023)
  • Table 118. Canada Gene expression analysis, by Techniques Types USD Million (2018-2023)
  • Table 119. Canada Gene expression analysis, by Service Types USD Million (2018-2023)
  • Table 120. Mexico Gene expression analysis, by Type USD Million (2018-2023)
  • Table 121. Mexico Gene expression analysis, by Application USD Million (2018-2023)
  • Table 122. Mexico Gene expression analysis, by Techniques Types USD Million (2018-2023)
  • Table 123. Mexico Gene expression analysis, by Service Types USD Million (2018-2023)
  • Table 124. Gene expression analysis: by Type(USD/Units)
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Research Programs/Design for This Report
  • Table 136. Key Data Information from Secondary Sources
  • Table 137. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Gene expression analysis: by Type USD Million (2018-2023)
  • Figure 5. Global Gene expression analysis: by Application USD Million (2018-2023)
  • Figure 6. Global Gene expression analysis: by Techniques Types USD Million (2018-2023)
  • Figure 7. Global Gene expression analysis: by Service Types USD Million (2018-2023)
  • Figure 8. South America Gene expression analysis Share (%), by Country
  • Figure 9. Asia Pacific Gene expression analysis Share (%), by Country
  • Figure 10. Europe Gene expression analysis Share (%), by Country
  • Figure 11. MEA Gene expression analysis Share (%), by Country
  • Figure 12. North America Gene expression analysis Share (%), by Country
  • Figure 13. Global Gene expression analysis: by Type USD/Units (2018-2023)
  • Figure 14. Global Gene expression analysis share by Players 2023 (%)
  • Figure 15. Global Gene expression analysis share by Players (Top 3) 2023(%)
  • Figure 16. Global Gene expression analysis share by Players (Top 5) 2023(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Illumina Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Illumina Inc. (United States) Revenue: by Geography 2023
  • Figure 20. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 21. Thermo Fisher Scientific (United States) Revenue: by Geography 2023
  • Figure 22. Bio-Rad Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 23. Bio-Rad Laboratories (United States) Revenue: by Geography 2023
  • Figure 24. F. Hoffmann-La Roche Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 25. F. Hoffmann-La Roche Ltd. (Switzerland) Revenue: by Geography 2023
  • Figure 26. Ge Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 27. Ge Healthcare (United States) Revenue: by Geography 2023
  • Figure 28. Pacific Biosciences of California (Unites States) Revenue, Net Income and Gross profit
  • Figure 29. Pacific Biosciences of California (Unites States) Revenue: by Geography 2023
  • Figure 30. Bgi (Denmark) Revenue, Net Income and Gross profit
  • Figure 31. Bgi (Denmark) Revenue: by Geography 2023
  • Figure 32. Perkinelmer (United States) Revenue, Net Income and Gross profit
  • Figure 33. Perkinelmer (United States) Revenue: by Geography 2023
  • Figure 34. Agilent Technologies Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 35. Agilent Technologies Inc. (United States) Revenue: by Geography 2023
  • Figure 36. Qiagen N.V (Germany) Revenue, Net Income and Gross profit
  • Figure 37. Qiagen N.V (Germany) Revenue: by Geography 2023
List of companies from research coverage that are profiled in the study
  • Illumina Inc. (United States)
  • Thermo Fisher Scientific (United States)
  • Bio-Rad Laboratories (United States)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Ge Healthcare (United States)
  • Pacific Biosciences of California (Unites States)
  • Bgi (Denmark)
  • Perkinelmer (United States)
  • Agilent Technologies Inc. (United States)
  • Qiagen N.V (Germany)
Select User Access Type

Key Highlights of Report


Mar 2024 150 Pages 51 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Illumina Inc. (United States), Thermo Fisher Scientific (United States), Bio-Rad Laboratories (United States), F. Hoffmann-La Roche Ltd. (Switzerland), Ge Healthcare (United States), Pacific Biosciences of California (Unites States), Bgi (Denmark), Perkinelmer (United States), Agilent Technologies Inc. (United States) and Qiagen N.V (Germany) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Real-Time PCR Has Risen As the Most Popularly Used Approach in Studies" is seen as one of major influencing trends for Gene expression analysis Market during projected period 2023-2030.
The Gene expression analysis market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Gene expression analysis Market Report?